AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 68 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,003,000 | +46.6% | 436,183 | +202.7% | 0.01% | +40.0% |
| Q4 2021 | $684,000 | +65.6% | 144,093 | +143.0% | 0.01% | +66.7% |
| Q2 2021 | $413,000 | -72.5% | 59,294 | -68.7% | 0.00% | -75.0% |
| Q1 2021 | $1,500,000 | +63.9% | 189,433 | +62.9% | 0.01% | +50.0% |
| Q4 2020 | $915,000 | -46.6% | 116,267 | -51.9% | 0.01% | -55.6% |
| Q3 2020 | $1,712,000 | +820.4% | 241,476 | +505.2% | 0.02% | +800.0% |
| Q1 2020 | $186,000 | -43.3% | 39,903 | -16.6% | 0.00% | -60.0% |
| Q2 2019 | $328,000 | +131.0% | 47,853 | +257.7% | 0.01% | +150.0% |
| Q2 2018 | $142,000 | +67.1% | 13,379 | -14.7% | 0.00% | +100.0% |
| Q4 2017 | $85,000 | – | 15,688 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $532,000 | 6.17% |
| Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
| GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
| Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
| Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
| Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
| Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
| Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |